| |
|
|
|
GenMark Diagnostics Inc.  
|
|
5.03 -0.13 (-0.03%) |
12-07 16:00 |
|
Open: |
5.12 |
Pre close: |
5.16 |
Target:
|
6.26 
|
|
High: |
5.25 |
Low: |
5 |
Resistance:
|
5.36
6.26
|
|
Volume: |
376,552 |
Market Cap: |
281M |
Support:
|
4.75
4.38
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.15
|
MACD |
MACD(12,26):
|
-0.08  |
|
MA(20): |
4.95 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
6.48 |
Stochastic Oscillator |
%K(14,3):
|
72.44 |
|
MA(250): |
6.05 |
%D(3): |
78.18 |
|
Average Volume(K) |
3-Month: |
41194
|
52-Week |
High:
|
8.81 |
|
10-Days: |
27655 |
Low: |
3.98 |
|
RSI |
RSI(14):
|
44.10 |
Change(%): |
14.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.970 |
Return on Equity (ttm) |
-88.0 |
Shares Out. (M) |
55.96 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-48.9 |
Shares Float (M) |
52.80 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.13 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
36.1 |
% Held by Institutions |
155.40 |
|
Forward EPS |
-0.630 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
6.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-5.19 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.72 |
|
Profit Margin |
-78.34 |
Operating Cash Flow
(M) |
-41.72 |
P/S |
230720336.00 |
|
Operating Margin |
-75.85 |
Levered Free Cash Flow
(M) |
-19.45 |
P/CF |
-6.75 |
|
|
|
|
|
|
